Novo Nordisk and Anthropic announced a collaboration to use AI to accelerate drug discovery, research and development. 🔹 Key Highlights 🤝 Novo Nordisk will adopt Anthropic models and Claude for Science across R&D and software engineering. 🧬 The companies will work on drug-discovery challenges identified by Novo’s scientists and computational teams. 🤖 The collaboration will develop tools for biological reasoning and specialized research workflows. ⚕️ The partnership aims to accelerate pharmaceutical research and drug discovery. 🌐 Novo is expanding its use of AI alongside its existing AI partnerships. 💡 Why It Matters The collaboration highlights the growing use of advanced AI models in pharmaceutical R&D, particularly for biological reasoning, research workflows and drug discovery. 🚀 Start Your 7-Day FREE ThinkSabio Trial https://www.thinksabio.com/ ThinkSabio — Stocks Simplified